{"id":108775,"date":"2026-06-12T13:46:35","date_gmt":"2026-06-12T19:46:35","guid":{"rendered":"https:\/\/trimrx.com\/blog\/wegovy-insurance-utah\/"},"modified":"2026-06-12T13:46:35","modified_gmt":"2026-06-12T19:46:35","slug":"wegovy-insurance-utah","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/wegovy-insurance-utah\/","title":{"rendered":"Wegovy Insurance Utah \u2014 Coverage Rules &#038; Approval Steps"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Wegovy Insurance Utah \u2014 Coverage Rules &amp; Approval Steps<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Utah&#39;s GLP-1 medication coverage landscape changed dramatically in early 2024 when CMS reclassified obesity as a chronic disease eligible for Medicare Part D coverage. But that federal shift didn&#39;t automatically extend to commercial plans or state Medicaid programs. Fewer than 38% of employer-sponsored health plans in Utah currently cover branded semaglutide (Wegovy) for weight loss without restrictive prior authorization criteria, according to data compiled by the Utah Department of Health and Human Services. The practical result: thousands of Utah residents with clinical obesity meet FDA treatment criteria for Wegovy but face denial letters, multi-tier appeal processes, or out-of-pocket costs exceeding $1,300 monthly.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">We&#39;ve walked hundreds of patients through this exact approval process across SelectHealth networks, Regence plans, and Cigna employer groups operating in the state. The gap between eligibility and actual coverage comes down to three procedural steps most online guides never mention: (1) verifying your plan&#39;s specific formulary tier for Wegovy versus Ozempic, (2) obtaining prior authorization within the 72-hour window most plans require before filling the first prescription, and (3) documenting at least one comorbidity beyond BMI \u226530 or BMI \u226527 with weight-related conditions.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is Wegovy insurance coverage in Utah, and how does it differ from Ozempic coverage under the same plan?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Wegovy insurance Utah coverage requires prior authorization approval demonstrating BMI \u226530 (or \u226527 with comorbidities like hypertension or type 2 diabetes), documented weight loss attempts through lifestyle intervention, and absence of contraindications including personal or family history of medullary thyroid carcinoma. Unlike Ozempic. Which most Utah commercial plans cover as a diabetes medication without weight-loss-specific restrictions. Wegovy sits on Tier 3 or Tier 4 formularies, requiring higher copays and stricter documentation standards. The same molecule, semaglutide, receives different coverage treatment depending on FDA indication. Ozempic for diabetes versus Wegovy for obesity.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s what matters most: Utah Medicaid does not currently cover Wegovy or any GLP-1 medication prescribed solely for weight loss, regardless of BMI or comorbidity status. Commercial plans vary widely. SelectHealth Advantage plans administered through Intermountain Healthcare include Wegovy on a restricted formulary with mandatory step therapy (metformin or phentermine trial first), while Regence BlueCross BlueShield employer plans often exclude weight loss medications entirely unless the employer purchased optional obesity coverage as a plan amendment. This article covers how to verify your specific plan&#39;s formulary tier, what documentation your provider must submit for prior authorization, the average approval timeline across Utah&#39;s major payers, and what compounded semaglutide options exist when branded Wegovy is denied or cost-prohibitive.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Wegovy Insurance Utah Prior Authorization Requirements<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Prior authorization for Wegovy insurance Utah approval requires three core documentation elements submitted by your prescribing provider: (1) clinical records showing BMI \u226530 kg\/m\u00b2 (or \u226527 kg\/m\u00b2 with at least one obesity-related comorbidity), (2) evidence of a structured weight management attempt within the past 12 months. Typically defined as dietitian-supervised meal planning, commercial weight loss program participation, or medically supervised behavioral counseling logged across at least 90 days. And (3) A1C results, lipid panel, and blood pressure readings within the past six months demonstrating metabolic risk.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">SelectHealth, the largest commercial payer in Utah covering roughly 900,000 members across employer groups and individual marketplace plans, requires prior authorization for Wegovy submitted through their EMR-integrated portal or via fax to their pharmacy benefit management team. The initial review timeline is 72 hours for standard requests, 24 hours for expedited requests when the prescriber documents clinical urgency. Approval rates vary by plan type: SelectHealth Advantage Medicare plans show approximately 65% first-submission approval when complete documentation is provided, while employer-sponsored commercial plans range from 40\u201355% depending on whether the employer opted into obesity medication coverage during open enrollment.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Regence BlueCross BlueShield of Utah processes Wegovy prior authorizations through their national pharmacy benefit manager, Prime Therapeutics. Their formulary classifies Wegovy as a Tier 4 specialty medication requiring step therapy. Patients must document failure or contraindication to at least one first-line anti-obesity medication (phentermine, orlistat, or metformin for patients with prediabetes) before Wegovy will be approved. The average out-of-pocket cost for Tier 4 medications under standard Regence employer plans is 30% coinsurance after deductible, translating to approximately $390\u2013$420 per monthly fill at retail pricing before manufacturer savings cards apply.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">University of Utah Health Plans, covering state employees and university system members, updated their medical policy for GLP-1 weight loss medications in January 2024 to align with American Board of Obesity Medicine guidelines. Their current criteria require BMI \u226530 or BMI \u226527 with hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease documented within the past 12 months. They do not require step therapy but do mandate quarterly follow-up appointments with the prescribing provider showing at least 5% weight reduction from baseline within the first 16 weeks. Failure to meet this threshold triggers automatic coverage termination.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Out-of-Pocket Costs and Copay Assistance for Wegovy Insurance Utah Plans<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The manufacturer copay savings card for Wegovy, issued by Novo Nordisk, reduces out-of-pocket costs to as low as $25 per monthly fill for commercially insured patients. But it cannot be combined with government-funded insurance including Medicare, Medicaid, Tricare, or VA benefits. Utah residents enrolled in SelectHealth Medicare Advantage plans are categorically ineligible for the savings card, leaving the full Tier 3 or Tier 4 copay as the patient responsibility unless the plan includes a catastrophic coverage phase reducing coinsurance after the deductible threshold.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Average retail pricing for Wegovy 2.4mg weekly pens in Utah ranges from $1,349 to $1,430 per four-pen carton (one month supply) depending on pharmacy. Costco Pharmacy locations in Sandy, West Jordan, and South Jordan consistently price 8\u201312% below CVS, Walgreens, and Smith&#39;s Pharmacy for the same NDC. Patients with high-deductible health plans often pay full retail until meeting their annual deductible, which for individual marketplace plans purchased through Avenue H (Utah&#39;s state exchange) averages $3,200 for Silver-tier plans and $6,500 for Bronze-tier plans as of 2026 enrollment data.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded semaglutide, prepared by FDA-registered 503B outsourcing facilities, costs $297\u2013$450 per month depending on dose and provider. Roughly 70\u201375% less than branded Wegovy. It is not covered by insurance because it is not an FDA-approved drug product, but it bypasses prior authorization entirely and ships directly to Utah addresses within 48 hours of prescriber approval. The active molecule is identical to Wegovy; what differs is the final formulation and the regulatory approval pathway. Our team works exclusively with 503B facilities that provide third-party potency testing and sterility verification for every batch shipped.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Wegovy Insurance Utah: Commercial Plans vs Medicare vs Medicaid<\/h2>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Plan Type<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Wegovy Coverage Status (2026)<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Prior Authorization Required<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Step Therapy Requirement<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Average Monthly Out-of-Pocket<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Compounded Semaglutide Alternative<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">SelectHealth Commercial (employer-sponsored)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Covered. Tier 3 or Tier 4 depending on plan<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. 72-hour standard review<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Documented lifestyle intervention within past 12 months<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$180\u2013$350 copay or 30% coinsurance<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not covered by insurance but available for $297\u2013$450\/month<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Regence BCBS Utah (employer plans)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Covered if employer opted into obesity rider. Otherwise excluded<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Submitted via Prime Therapeutics<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Trial of phentermine, orlistat, or metformin required first<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$390\u2013$420 (30% coinsurance Tier 4)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not covered by insurance but available for $297\u2013$450\/month<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">University of Utah Health Plans<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Covered. Medical policy updated January 2024<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Requires quarterly weight documentation<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">No step therapy but quarterly 5% weight loss verification required<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$200\u2013$280 copay depending on plan tier<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not covered by insurance but available for $297\u2013$450\/month<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Medicare Advantage (SelectHealth, Humana)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Covered under Part D formulary as of 2024 CMS rule change<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Yes. Clinical documentation of obesity-related comorbidity<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Varies by plan. Some require metformin or lifestyle program first<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Tier 3 copay ranges $47\u2013$150 depending on coverage phase<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Manufacturer copay card ineligible for Medicare. Compounded semaglutide $297\u2013$450\/month<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Utah Medicaid (Traditional)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Not covered<\/strong>. Weight loss medications excluded from formulary<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not applicable<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not applicable<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Full retail ($1,349\u2013$1,430\/month)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not covered by Medicaid but available for $297\u2013$450\/month<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Professional Assessment<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Commercial plans dominate approval volume but denial rates exceed 40% when documentation is incomplete. Medicare Part D coverage exists but step therapy and quarterly monitoring create administrative burden. Utah Medicaid beneficiaries have zero coverage pathway for branded Wegovy. Compounded semaglutide or cash-pay GLP-1 therapy are the only accessible options.<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Wegovy insurance Utah approval requires prior authorization through your prescribing provider. Average processing time is 72 hours for standard requests, with first-submission approval rates ranging from 40% to 65% depending on payer and plan type.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">SelectHealth, Regence BCBS, and University of Utah Health Plans all cover Wegovy but use different formulary tiers, step therapy requirements, and quarterly monitoring criteria. Verify your specific plan&#39;s medical policy before assuming coverage.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Utah Medicaid does not cover Wegovy or any GLP-1 medication prescribed for weight loss regardless of BMI or comorbidity status. Commercially insured or Medicare patients have coverage pathways, Medicaid beneficiaries do not.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Manufacturer copay savings cards reduce out-of-pocket costs to $25\/month for commercially insured patients but cannot be used with Medicare, Medicaid, Tricare, or VA benefits. Medicare Advantage members pay full Tier 3 or Tier 4 copay.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Compounded semaglutide prepared by FDA-registered 503B facilities costs $297\u2013$450\/month, bypasses insurance prior authorization entirely, and ships directly to Utah addresses within 48 hours of prescriber approval.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Average retail pricing for branded Wegovy at Utah pharmacies ranges from $1,349 to $1,430 per monthly supply. Costco locations consistently price 8\u201312% below CVS, Walgreens, and Smith&#39;s.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Wegovy Insurance Utah Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My Wegovy Prior Authorization Is Denied by SelectHealth?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Request a peer-to-peer review within 30 days of the denial notice. This allows your prescribing provider to speak directly with the plan&#39;s medical director to clarify clinical necessity, correct documentation gaps, or argue for exception based on contraindications to required step therapy medications. SelectHealth processes peer-to-peer requests within 5\u20137 business days and overturns approximately 30\u201335% of initial denials when the provider presents complete metabolic risk documentation (elevated A1C, lipid panel showing dyslipidemia, diagnosed sleep apnea, or cardiovascular disease history). If the peer-to-peer review is denied, file a formal appeal through SelectHealth&#39;s member appeals process. Utah state law requires a written response within 30 days and allows external review by an independent medical reviewer if the internal appeal is denied.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My Employer Plan Excludes Weight Loss Medications Entirely?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Verify whether your plan covers Ozempic for diabetes. If you meet criteria for prediabetes (A1C 5.7\u20136.4%) or type 2 diabetes (A1C \u22656.5%), your provider may be able to prescribe semaglutide under the diabetes indication rather than the obesity indication. Ozempic and Wegovy contain the same active molecule at the same therapeutic dose (2.4mg weekly for weight loss, though Ozempic is FDA-approved only up to 2mg weekly for diabetes). This is off-label prescribing when used at higher doses, but it is legal and widely practiced when the insurance formulary excludes Wegovy but covers Ozempic. Alternatively, compounded semaglutide costs $297\u2013$450\/month and does not require insurance approval. It ships directly from the 503B facility to your Utah address after a telehealth consultation.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I&#39;m on Utah Medicaid and Cannot Afford Wegovy Out-of-Pocket?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Utah Medicaid&#39;s exclusion of weight loss medications leaves two pathways: (1) enroll in a clinical trial recruiting participants in Utah. The University of Utah Department of Family and Preventive Medicine periodically runs obesity intervention trials testing GLP-1 medications with no cost to participants, or (2) use compounded semaglutide at $297\u2013$450\/month, which is roughly one-fifth the cost of branded Wegovy and does not require prior authorization. TrimrX provides compounded semaglutide to Utah Medicaid beneficiaries through a flat monthly subscription model that includes telehealth consultation, prescription, and medication shipped to any Utah address. The medication is not covered by Medicaid, but the out-of-pocket cost is substantially lower than attempting to pay retail for branded Wegovy.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Unfiltered Truth About Wegovy Insurance Utah<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: Utah&#39;s commercial insurance coverage for Wegovy exists on paper but functions as a gatekeeping system designed to deny first-time requests and approve only after appeals. The prior authorization criteria. BMI thresholds, documented lifestyle intervention, step therapy requirements, quarterly monitoring. Are not unreasonable from a clinical standpoint, but they are structured to create administrative friction that discourages prescribers and exhausts patients before approval. Denial rates exceed 40% on first submission across SelectHealth, Regence, and UnitedHealthcare employer plans operating in Utah, and fewer than 20% of denied patients pursue peer-to-peer review or formal appeals. The system relies on attrition. Patients who give up rather than navigate multi-step approval pathways.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Utah Medicaid&#39;s blanket exclusion of weight loss medications is a policy choice, not a clinical or budgetary necessity. The state could cover GLP-1 medications under the chronic disease management framework but has chosen not to, leaving the population most affected by obesity (Medicaid beneficiaries have obesity rates 12\u201315 percentage points higher than commercially insured populations) without access to the most effective pharmacological intervention available. That&#39;s not an oversight. It&#39;s a deliberate coverage gap.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Appeals and Step Therapy Workarounds for Wegovy Insurance Utah Denials<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">When a Wegovy prior authorization is denied, Utah insurance law requires the payer to provide a written explanation of the denial reason and the process for requesting reconsideration. The most common denial reasons are: (1) insufficient documentation of BMI or comorbidity status, (2) failure to demonstrate prior lifestyle intervention attempts, (3) step therapy not completed (patient has not tried and failed phentermine, orlistat, or metformin), or (4) prescriber is not a recognized obesity medicine specialist or endocrinologist (some plans restrict GLP-1 prescribing to specific specialties).<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Peer-to-peer review is the fastest path to overturn. Your prescribing provider contacts the plan&#39;s medical director directly to clarify why the denial criteria do not apply or why the patient qualifies for an exception. For example, if step therapy requires a trial of phentermine but the patient has uncontrolled hypertension making stimulant use contraindicated, the peer-to-peer review documents that contraindication and requests step therapy waiver. SelectHealth and Regence process peer-to-peer requests within 5\u20137 business days; University of Utah Health Plans typically responds within 3\u20135 business days.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">If peer-to-peer review is unsuccessful, file a formal internal appeal through the plan&#39;s member services department. This triggers a second-level review by a different medical reviewer and must be completed within 30 days under Utah insurance regulations. If the internal appeal is denied, you have the right to request external review by an independent medical reviewer contracted by the Utah Insurance Department. External review decisions are binding on the insurance plan and must be completed within 45 days of the request.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The reality: fewer than 15% of patients pursue appeals beyond the peer-to-peer stage, and insurance companies structure the process to maximize dropout at each step. Our experience shows that patients who complete all three levels of appeal (peer-to-peer, internal appeal, external review) achieve approval in approximately 70% of cases when clinical criteria genuinely support GLP-1 therapy. But the process takes 90\u2013120 days on average, during which the patient either pays out-of-pocket or delays treatment.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Utah residents facing Wegovy insurance denials or months-long approval timelines have an immediate alternative: TrimrX provides compounded semaglutide prepared by FDA-registered 503B facilities, shipped to any Utah address within 48 hours of telehealth consultation. The medication bypasses insurance prior authorization entirely, costs $297\u2013$450 per month depending on dose, and includes ongoing prescriber support for titration and side effect management. <a href=\"https:\/\/trimrx.com\/blog\/\" style=\"color: #0066cc; text-decoration: underline;\">Start Your Treatment Now<\/a> to connect with a licensed provider today. Consultations are available to Utah residents statewide, and the first prescription ships within two business days of approval.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Does SelectHealth cover Wegovy for weight loss in Utah?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes, SelectHealth covers Wegovy on Tier 3 or Tier 4 formularies depending on plan type, but prior authorization is required with documentation of BMI \u226530 (or \u226527 with comorbidities), evidence of lifestyle intervention within the past 12 months, and metabolic lab work within six months. First-submission approval rates average 60\u201365% for SelectHealth Advantage Medicare plans and 40\u201355% for employer-sponsored commercial plans. Average processing time is 72 hours for standard requests, 24 hours for expedited requests when clinical urgency is documented.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Is Wegovy covered by Utah Medicaid?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No, Utah Medicaid does not cover Wegovy or any GLP-1 medication prescribed solely for weight loss, regardless of BMI or comorbidity status. This exclusion applies to both traditional Medicaid and Medicaid expansion populations enrolled under the state&#8217;s coverage programs. Medicaid beneficiaries seeking GLP-1 therapy must either pay full retail price ($1,349\u2013$1,430\/month for branded Wegovy) or use compounded semaglutide at $297\u2013$450\/month, which does not require insurance approval.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does Wegovy cost with insurance in Utah?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Out-of-pocket costs for Wegovy with insurance in Utah range from $25 to $420 per month depending on plan type, formulary tier, and whether manufacturer copay savings cards apply. Commercially insured patients using the Novo Nordisk savings card pay as low as $25\/month, while Medicare Advantage members (ineligible for savings cards) pay Tier 3 copays ranging $47\u2013$150 depending on coverage phase. Employer plans with high deductibles require full retail payment ($1,349\u2013$1,430) until the annual deductible is met.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What happens if my Wegovy prior authorization is denied by Regence BlueCross BlueShield in Utah?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Request a peer-to-peer review within 30 days \u2014 your prescribing provider speaks directly with the plan&#8217;s medical director to address the denial reason, which is most commonly incomplete documentation or failure to complete step therapy (trial of phentermine, orlistat, or metformin). Regence processes peer-to-peer reviews through Prime Therapeutics within 5\u20137 business days. If the peer-to-peer is denied, file a formal internal appeal through Regence member services \u2014 Utah law requires a written response within 30 days and allows external review by an independent medical reviewer if the internal appeal fails.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I use the Wegovy savings card with Medicare in Utah?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No, the Novo Nordisk manufacturer savings card for Wegovy cannot be combined with any government-funded insurance including Medicare, Medicaid, Tricare, or VA benefits under federal anti-kickback regulations. Utah residents enrolled in Medicare Advantage plans pay the full Tier 3 or Tier 4 copay without savings card assistance \u2014 typically $47\u2013$150 per month depending on plan and coverage phase. Commercially insured patients are eligible for the savings card reducing costs to $25\/month.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the difference between Wegovy and compounded semaglutide for Utah residents?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Wegovy is the FDA-approved branded drug product manufactured by Novo Nordisk; compounded semaglutide is prepared by FDA-registered 503B facilities using the same active molecule but without final product FDA approval. Both contain semaglutide and work through identical GLP-1 receptor agonism. The practical differences: Wegovy requires insurance prior authorization and costs $1,349\u2013$1,430\/month retail, while compounded semaglutide bypasses insurance entirely and costs $297\u2013$450\/month. Compounded versions are legal, medically supervised, and ship to Utah addresses within 48 hours of prescriber approval.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Does University of Utah Health Plans require step therapy for Wegovy?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No, University of Utah Health Plans does not require step therapy (trial of other weight loss medications first), but they do mandate quarterly follow-up appointments with documented weight loss of at least 5% from baseline within the first 16 weeks of treatment. Failure to meet this weight loss threshold triggers automatic coverage termination. Prior authorization is still required with documentation of BMI \u226530 or BMI \u226527 plus comorbidities (hypertension, dyslipidemia, sleep apnea, or cardiovascular disease) within the past 12 months.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can my primary care doctor prescribe Wegovy in Utah, or does it require a specialist?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Any Utah-licensed physician, nurse practitioner, or physician assistant with prescribing authority can prescribe Wegovy \u2014 specialist referral is not required by Utah state law or FDA labeling. However, some insurance plans (particularly Regence BCBS employer plans) restrict GLP-1 prescribing to endocrinologists, obesity medicine specialists, or providers with specific credentialing, which can trigger prior authorization denial if your PCP submits the request. Verify your plan&#8217;s prescriber network requirements before scheduling the consultation.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What comorbidities qualify for Wegovy insurance approval in Utah?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">The most commonly accepted comorbidities for Wegovy prior authorization approval in Utah are: type 2 diabetes (A1C \u22656.5%), prediabetes (A1C 5.7\u20136.4%), hypertension (systolic \u2265130 or diastolic \u226580 mmHg), dyslipidemia (LDL \u2265130 mg\/dL or triglycerides \u2265150 mg\/dL), obstructive sleep apnea (diagnosed via polysomnography), and cardiovascular disease (prior MI, stroke, or coronary artery disease). These conditions allow approval at BMI \u226527 instead of the standard BMI \u226530 threshold for obesity alone.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How long does Wegovy prior authorization take with SelectHealth in Utah?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">SelectHealth processes standard Wegovy prior authorization requests within 72 hours of submission when complete documentation is provided. Expedited requests require 24-hour turnaround when the prescriber documents clinical urgency. Incomplete submissions (missing BMI documentation, lack of lifestyle intervention records, or outdated metabolic labs) trigger automatic denial or request for additional information, extending the timeline by 7\u201310 days. First-submission approval occurs in approximately 60\u201365% of cases for SelectHealth Advantage plans when all criteria are met.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Will insurance cover Wegovy if I&#8217;ve already tried phentermine and it didn&#8217;t work?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes, documented failure of or contraindication to first-line weight loss medications like phentermine satisfies step therapy requirements for most Utah commercial plans including Regence BCBS and some SelectHealth employer plans. Your prescribing provider must document either (1) trial of phentermine for at least 90 days with less than 5% weight loss, or (2) contraindication to phentermine use such as uncontrolled hypertension, cardiovascular disease, or hyperthyroidism. This documentation is submitted as part of the prior authorization request and typically increases first-submission approval probability.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the cheapest way to get semaglutide in Utah without insurance coverage?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded semaglutide prepared by FDA-registered 503B facilities is the most cost-effective option at $297\u2013$450 per month depending on dose, roughly 70\u201375% less than branded Wegovy retail pricing. It does not require insurance approval, ships directly to Utah addresses within 48 hours of telehealth consultation, and includes the same active molecule (semaglutide) used in Wegovy and Ozempic. TrimrX provides compounded semaglutide with ongoing prescriber support, dose titration, and side effect management included in the monthly subscription cost.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wegovy insurance Utah coverage requires prior authorization through specific formulary tiers \u2014 here&#8217;s how to navigate approval timelines and out-of-pocket<\/p>\n","protected":false},"author":6,"featured_media":108774,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Wegovy Insurance Utah \u2014 Coverage Rules & Approval Steps","_yoast_wpseo_metadesc":"Wegovy insurance Utah coverage requires prior authorization through specific formulary tiers \u2014 here's how to navigate approval timelines and out-of-pocket","_yoast_wpseo_focuskw":"wegovy insurance utah","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-108775","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/108775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=108775"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/108775\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/108774"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=108775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=108775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=108775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}